PODXL and liver dysplastic nodule: A study conducted in STZ-induced DN rats treated with pioglitazone for 8 weeks showed that the decrease in KI induced a notable improvement in DN, associating it with the increased expression of podocalyxin, a protein related to podocyte architecture, and protection against disease progression [68].